Commentary
T cell activity in successful treatment of chronic urticaria with omalizumab
-
* Corresponding author: Víctor Matheu victor.matheu@med.lu.se
Clinical and Molecular Allergy 2011, 9:11 doi:10.1186/1476-7961-9-11
No comments have yet been made on this article.